Status:
COMPLETED
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Lead Sponsor:
Hospital General de Requena
Conditions:
Asthma
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Combined inhaled treatment with long acting adrenergics and steroids in an unique inhaler plays an important role in the management of non-mild asthma. Some studies have demonstrated that the use of s...
Eligibility Criteria
Inclusion
- Moderate-severe asthma
- Stable asthma
- 18-75 years old
Exclusion
- Exacerbation of asthma
- Instability with the study treatment
- Other cardiopulmonary disease
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00850265
Start Date
March 1 2008
End Date
December 1 2008
Last Update
March 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General de Requena
Requena-Valencia, Valencia, Spain, 46340